Compound Global Advisors LLC Invests $1.11 Million in HCA Healthcare, Inc. (NYSE:HCA)

Compound Global Advisors LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,703 shares of the company’s stock, valued at approximately $1,111,000. HCA Healthcare accounts for approximately 4.5% of Compound Global Advisors LLC’s investment portfolio, making the stock its 8th largest holding.

A number of other institutional investors have also modified their holdings of the business. Atomi Financial Group Inc. bought a new position in shares of HCA Healthcare during the third quarter worth about $233,000. Valeo Financial Advisors LLC increased its stake in shares of HCA Healthcare by 11.5% in the third quarter. Valeo Financial Advisors LLC now owns 1,060 shares of the company’s stock valued at $431,000 after purchasing an additional 109 shares during the period. McGlone Suttner Wealth Management Inc. acquired a new stake in HCA Healthcare in the 3rd quarter valued at approximately $235,000. Sound Income Strategies LLC grew its stake in shares of HCA Healthcare by 82.2% in the third quarter. Sound Income Strategies LLC now owns 634 shares of the company’s stock worth $258,000 after purchasing an additional 286 shares in the last quarter. Finally, Redhawk Wealth Advisors Inc. acquired a new stake in HCA Healthcare in the third quarter worth about $926,000. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. TD Cowen reduced their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Barclays cut their price objective on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a report on Monday, January 27th. Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Morgan Stanley cut their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Finally, Bank of America reduced their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

Insider Activity at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

HCA Healthcare Trading Down 1.2 %

Shares of NYSE:HCA opened at $318.28 on Tuesday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The firm has a fifty day moving average of $313.75 and a two-hundred day moving average of $353.51. The firm has a market capitalization of $80.62 billion, a P/E ratio of 14.49, a price-to-earnings-growth ratio of 1.11 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the business posted $5.90 earnings per share. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.90%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is currently 12.02%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.